April 10 2012 Issue

1) Developing epilepsy after febrile seizures and 2) Topic of the month: Obesity and the neurology patient. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Levy Sander about his paper on developing epilepsy after febrile seizures. Dr. Chafic Karam is reading our e-Pearl of the week about neuromyelitis optica. In the next part of the podcast Dr. Ted Burns interviews Dr. Jeff Burns about the link between dementia and obesity. Next week, Dr. Brett Kissela will interview Dr. Mitch Elkind about stroke and obesity. The participants had nothing to disclose except Prof. Sander, Drs. Karam, Ted Burns, and Jeff Burns.Prof. Sander serves on scientific advisory boards for GlaxoSmithKline, Eisai Inc., ViroPharma Incorporated, and UCB; has received funding for travel from UCB and Janssen; serves on the editorial boards of Lancet Neurology, Epileptic Disorders, and Epilepsia; serves on the speakers' bureaus of UCB and GlaxoSmithKline; received research support from UCB (institutional), the NIH, CBRC, European Union Seventh Framework Programme, Wellcome Trust, National Epilepsie Fonds Nederland, and The Brain Research Trust; and his current post is endowed by the UK Epilepsy Society. Dr. Karam serves on the editorial team for the Neurology Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Jeff Burns serves on the editorial board of the Journal of Alzheimer's Disease; has served on a scientific advisory board for the American Academy of Physician Education; has received publishing royalties for Early Diagnosis and Treatment of Mild Cognitive Impairment (Wiley Press, 2008) and Dementia: An Atlas of Investigation and Diagnosis (Clinical Publishing, 2007); serves on the speakers' bureau for Novartis; has served as a consultant for Medacorp Consulting, Johnson County Clinical Trials, and PRA International; receives research support from Elan Corporation, Janssen, Wyeth, Pfizer Inc, Danone, and the Dana Foundation; and has served as an expert witness in legal proceedings regarding competency.